Bayforest Capital LTD Agios Pharmaceuticals, Inc. Transaction History
Bayforest Capital LTD
- $79.8 Billion
- Q4 2024
A detailed history of Bayforest Capital LTD transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Bayforest Capital LTD holds 24 shares of AGIO stock, worth $806. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24Holding current value
$806% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AGIO
# of Institutions
244Shares Held
59.9MCall Options Held
270KPut Options Held
332K-
Farallon Capital Management LLC San Francisco, CA5.67MShares$191 Million0.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$189 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$163 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$118 Million2.3% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.42MShares$81.5 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.84B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...